Patent details

EP3202459 Title: ACTRIIB ANTAGONISTS AND DOSING AND USES THEREOF FOR TREATING OBESITY OR TYPE 2 DIABETES BY REGULATING BODY FAT CONTENT

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP3202459
WO Application Number:
Type:
European Patent Granted for NL
Status:
Deemed not to be granted according to art. 52.4a or 52.6 ROW
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP16195379.9
WO Publication Number:
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
United States of America (US)
Publications:

Dates

Filing date:
09/09/2010
Grant date:
14/04/2021
EP Publication Date:
09/08/2017
WO Publication Date:
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
14/04/2021
EP B1 Publication Date:
14/04/2021
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
08/09/2030
Lapsed By Expiration Date:
Revocation Date:
Invalidity Date:
14/04/2021
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
14/04/2021
 
 

 

Name:
Acceleron Pharma Inc.
Address:
128 Sidney Street, Cambridge, MA 02139, United States of America (US)

Inventor

1

Name:
SEEHRA, Jasbir
Address:
Lexington, MA Massachusetts 02421-6818, United States of America (US)

2

Name:
KNOPF, John
Address:
Carlisle, MA Massachusetts 01741, United States of America (US)

3

Name:
ATTIE, Ken
Address:
Boston, MA Massachusetts 02116, United States of America (US)

Priority

Priority Patent Number:
276287 P
Priority Date:
09/09/2009
Priority Country:
United States of America (US)

Classification

IPC or IDT classification:
A61K 31/663; A61K 38/17; A61P 3/04; C07K 14/705;

Publication

Bulletin

1

Bulletin Heading:
VRV
Journal edition number:
38/21
Publication date:
22/09/2021
Description:
Lapse or annulment

2

Bulletin Heading:
EP2
Journal edition number:
15/21
Publication date:
14/04/2021
Description:
European patents granted for the Netherlands

European Patent Bulletin

1

Issue number:
202120
Publication date:
19/05/2021
Description:
Application number/publication number of the divisional application (Art. 76) changed

2

Issue number:
202115
Publication date:
14/04/2021
Description:
Grant (B1)

Annual Fee

Annual Fee(s) Due Date:
Annual Fee Number:
Last Annual Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Document Description Number of pages File Type